Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Why Adobe Is Trading Lower By 17%, Here Are 49 Stocks Moving In Thursday's Mid-Day Session

Published 15/09/2022, 18:03
Updated 15/09/2022, 18:40
© Reuters.  Why Adobe Is Trading Lower By 17%, Here Are 49 Stocks Moving In Thursday's Mid-Day Session

© Reuters. Why Adobe Is Trading Lower By 17%, Here Are 49 Stocks Moving In Thursday's Mid-Day Session

Gainers

  • HeartBeam, Inc. (NASDAQ: BEAT) shares surged 58% to $1.96 after the company announced its patent for a 12-lead electrocardiogram patch monitor intended for detection of acute coronary syndrome and cardiac arrhythmia was issued by the USPTO.
  • NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) gained 43.5% to $24.20 after the company announced Dong-A has licensed its global exclusive development rights of DA-1241 for type 2 diabetes and non-alcoholic fatty hepatitis and DA-1726 for obesity and non-alcoholic fatty hepatitis to NeuroBo.
  • ZW Data Action Technologies Inc. (NASDAQ: CNET) surged 43% to $0.9499. ZW Data Action Technologies reported planned acquisition of Henan Baodun.
  • AMTD Digital Inc. (NYSE: HKD) shares jumped 39.9% to $265.00 after jumping 312% on Wednesday.
  • Nabriva Therapeutics plc (NASDAQ: NBRV) gained 38% to $0.2650 after the company announced it will effect a 1-for-25 reverse stock split of its outstanding ordinary shares, which will be effective on September 16, 2022.
  • Addentax Group Corp. (NASDAQ: ATXG) shares rose 30.2% to $6.22 after jumping 17% on Wednesday.
  • STORE Capital Corporation (NYSE: STOR) jumped 20.3% to $32.22 after the company announced it will be acquired by GIC and Oak Street in a $14 billion transaction.
  • Faraday Future Intelligent Electric Inc. (NASDAQ: FFIE) rose 19.4% to $1.1299.
  • Secoo Holding Limited (NASDAQ: SECO) jumped 19.1% to $0.3097 after Aladdin Technology Group agreed to invest RMB1.3 million in the company.
  • Novo Integrated Sciences, Inc. (NASDAQ: NVOS) gained 18% to $1.2036.
  • Salarius Pharmaceuticals, Inc. (NASDAQ: SLRX) gained 16.2% to $0.24.
  • Republic First Bancorp, Inc. (NASDAQ: FRBK) jumped 15.8% to $3.00 as the company announced a strategic review; in light of inquiries by multiple parties expressing interest in one or more potential strategic transactions with the company.
  • Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) shares rose 13.9% to $0.2449. Sonnet BioTherapeutics, last month, posted a Q3 loss of $0.13 per share.
  • Canoo Inc. (NASDAQ: GOEV) gained 11.7% to $2.9050. Canoo Chairman, CEO Tony Aquila disclosed the purchase of 200k shares of the company’s common stock at an average price of $2.58 per share.
  • Enochian Biosciences, Inc. (NASDAQ: ENOB) rose 11.1% to $2.00 after declining around 6% on Wednesday.
  • HTG Molecular Diagnostics, Inc. (NASDAQ: HTGM) jumped 10.5% to $0.84.
  • ImmunityBio, Inc. (NASDAQ: IBRX) gained 10% to $7.05.
  • EVgo, Inc. (NASDAQ: EVGO) surged 10.1% to $10.23. EVgo launched Connect the Watts National EV Charging Recognition Program.
  • Wynn Resorts, Limited (NASDAQ: NASDAQ:WYNN) climbed 9.9% to $66.70. Credit Suisse (SIX:CSGN) upgraded Wynn Resorts from Neutral to Outperform.
  • Navidea Biopharmaceuticals, Inc. (NYSE: NAVB) surged 9.9% to $0.2749.
  • China Liberal Education Holdings Limited (NASDAQ: CLEU) gained 9.3% to $0.9710.
  • Ra Medical Systems, Inc. (NASDAQ: RMED) rose 8.9% to $0.1742. Ra Medical Systems recently announced a reverse merger agreement with Catheter Precision.
  • Humana Inc . (NYSE: NYSE:HUM) rose 8.2% to $496.26 after the company raised FY22 adjusted EPS guidance above estimates. The company also issued FY25 adjusted EPS guidance of $37 per share.
  • Roku, Inc. (NASDAQ: ROKU) jumped 7.7% to $73.58.
  • Amyris, Inc. (NASDAQ: AMRS) gained 6% to $4.15.
Losers
  • Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) fell 49.6% to $18.90. Shuttle Pharmaceuticals was awarded new HDAC inhibitor patents for cancer treatment.
  • Color Star Technology Co., Ltd. (NASDAQ: CSCW) dropped 44.8% to $0.0651 after the company announced a $5.6 million registered direct offering priced at $0.08 per unit.
  • IronNet, Inc. (NASDAQ: IRNT) shares dipped 43.9% to $1.2350 after the company reported worse-than-expected Q2 EPS and sales results. The company also withdrew its FY23 guidance in light of management transitions, restructuring and underperformance of current quarter.
  • Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX) declined 39.5% to $0.2297 after the company announced the combination of subcutaneous ELX-02 with ivacaftor did not achieve statistical significance for efficacy endpoints in Phase 2 study in Class 1 cystic fibrosis.
  • Omeros Corporation (NASDAQ: OMER) fell 28.2% to $3.87 after the company reported Narsoplimab treatment results in critically ill COVID-19 patients in I-SPY COVID trial.
  • Avenue Therapeutics, Inc. (NASDAQ: ATXI) shares fell 24.4% to $0.2685 after gaining around 53% on Wednesday.
  • Aditxt, Inc. (NASDAQ: ADTX) fell 22.8% to $8.83. Aditxt announced a 1-for-50 reverse stock split effective on September 14, 2022.
  • Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) shares fell 22% to $ 24.05. Rhythm Pharmaceuticals priced its 4.8 million share public offering of common stock at $26 per share.
  • Esports Entertainment Group, Inc. (NASDAQ: GMBL) fell 20.1% to $0.3355 after the company reported a proposed public offering of common stock and warrants.
  • Adobe Inc. (NASDAQ: NASDAQ:ADBE) dropped 17% to $307.25 after the company reported Q3 earnings results, issued Q4 sales guidance below estimates and announced it will acquire Figma for approximately $20 billion in cash and stock.
  • Akerna Corp. (NASDAQ: KERN) fell 16.4% to $0.1379.
  • SciSparc Ltd. (NASDAQ: SPRC) declined 15.7% to $0.8129. SciSparc announced it entered into an agreement to acquire Wellution for $20 million.
  • Arconic Corp (NYSE: ARNC) fell 15.1% to $21.64 as the company lowered its FY22 sales outlook from $9.6 billion-$10 billion to $9.2 billion-$9.5 billion. The company also said it sees Q3 Adjusted EBITDA to be in the range of $135 million to $150 million.
  • Wearable Devices Ltd. (NASDAQ: WLDS) fell 14.2% to $ 2.53 on post-IPO volatility after the stock opened for trade on Tuesday.
  • The Oncology Institute, Inc. (NASDAQ: TOI) dropped 13.6% to $4.31.
  • IDEAYA Biosciences, Inc. (NASDAQ: IDYA) fell 13.3% to $10.85. IDEAYA priced its 7.62 million share public offering of common stock at $10.50 per share.
  • NLS Pharmaceutics AG (NASDAQ: NLSP) dropped 13.3% to $0.90.
  • CF Acquisition Corp. VI (NASDAQ: CFVI) fell 13.3% to $12.03.
  • RenovoRx, Inc. (NASDAQ: RNXT) declined 12.5% to $2.30.
  • First Wave BioPharma, Inc. (NASDAQ: FWBI) fell 12.4% to $2.2126 after dropping 12% on Wednesday.
  • Array Technologies, Inc. (NASDAQ: ARRY) declined 11.7% to $17.55. MuddyWatersResearch discussed short report on Zer0es.tv.
  • CVR Energy, Inc. (NYSE: CVI) fell 10.6% to $29.27. Wolfe Research downgraded CVR Energy from Outperform to Peer Perform.
  • Spectrum Brands Holdings, Inc. (NYSE: SPB) dropped 10.5% to $52.56. Spectrum Brands' will oppose attempt to block the U.S. Department of Justice's Opposition to the sale of its Hardware and Home Improvement division to ASSA ABLOY.
  • PBF Energy Inc. (NYSE: PBF) fell 7.7% to $28.09. Shares of oil companies traded lower after rail companies and union negotiators came to a tentative agreement, averting a railroad strike. A strike would have caused supply shortages and lifted oil prices.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.